A detailed history of Choreo, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Choreo, LLC holds 44,901 shares of AZN stock, worth $3.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
44,901
Previous 51,930 13.54%
Holding current value
$3.7 Million
Previous $3.82 Million 17.79%
% of portfolio
0.04%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

SELL
$64.87 - $75.0 $455,971 - $527,175
-7,029 Reduced 13.54%
44,901 $3.14 Million
Q1 2025

May 06, 2025

BUY
$65.37 - $77.96 $101,650 - $121,227
1,555 Added 3.09%
51,930 $3.82 Million
Q4 2024

Jan 27, 2025

SELL
$63.2 - $79.58 $105,354 - $132,659
-1,667 Reduced 3.2%
50,375 $3.3 Million
Q3 2024

Nov 07, 2024

BUY
$76.67 - $87.62 $318,717 - $364,236
4,157 Added 8.68%
52,042 $4.06 Million
Q2 2024

Aug 06, 2024

BUY
$66.81 - $80.83 $2.99 Million - $3.62 Million
44,808 Added 1456.22%
47,885 $3.73 Million
Q1 2024

May 02, 2024

BUY
$61.03 - $69.57 $187,789 - $214,066
3,077 New
3,077 $208,000
Q3 2019

Jun 04, 2020

SELL
$40.12 - $45.47 $196,226 - $222,393
-4,891 Closed
0 $0
Q2 2019

Jun 04, 2020

SELL
$37.28 - $41.68 $35,788 - $40,012
-960 Reduced 16.41%
4,891 $202,000
Q1 2019

Jun 04, 2020

SELL
$35.49 - $43.02 $25,481 - $30,888
-718 Reduced 10.93%
5,851 $237,000
Q4 2018

Jun 04, 2020

SELL
$36.86 - $41.49 $40,840 - $45,970
-1,108 Reduced 14.43%
6,569 $249,000
Q2 2018

Jun 04, 2020

SELL
$34.55 - $37.05 $54,969 - $58,946
-1,591 Reduced 17.17%
7,677 $270,000
Q1 2018

Jun 04, 2020

BUY
$32.97 - $36.63 $29,837 - $33,150
905 Added 10.82%
9,268 $324,000
Q4 2017

Jun 04, 2020

BUY
$32.09 - $34.78 $17,200 - $18,642
536 Added 6.85%
8,363 $290,000
Q3 2017

Jun 04, 2020

BUY
$28.96 - $34.0 $226,669 - $266,118
7,827
7,827 $265,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $255B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Choreo, LLC Portfolio

Follow Choreo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.